Withania somnifera root extract has been used traditionally in ayurvedic system of medicine as a memory enhancer. Present study explores the ameliorative effect of withanolide A, a major component of withania root extract and its molecular mechanism against hypoxia induced memory impairment. Withanolide A was administered to male Sprague Dawley rats before a period of 21 days pre-exposure and during 07 days of exposure to a simulated altitude of 25,000 ft. Glutathione level and glutathione dependent free radicals scavenging enzyme system, ATP, NADPH level, γ-glutamylcysteinyl ligase (GCLC) activity and oxidative stress markers were assessed in the hippocampus. Expression of apoptotic marker caspase 3 in hippocampus was investigated by immunohistochemistry. Transcriptional alteration and expression of GCLC and Nuclear factor (erythroid-derived 2)–related factor 2 (Nrf2) were investigated by real time PCR and immunoblotting respectively. Exposure to hypobaric hypoxia decreased reduced glutathione (GSH) level and impaired reduced gluatathione dependent free radical scavenging system in hippocampus resulting in elevated oxidative stress. Supplementation of withanolide A during hypoxic exposure increased GSH level, augmented GSH dependent free radicals scavenging system and decreased the number of caspase and hoescht positive cells in hippocampus. While withanolide A reversed hypoxia mediated neurodegeneration, administration of buthionine sulfoximine along with withanolide A blunted its neuroprotective effects. Exogenous administration of corticosterone suppressed Nrf2 and GCLC expression whereas inhibition of corticosterone synthesis upregulated Nrf2 as well as GCLC. Thus present study infers that withanolide A reduces neurodegeneration by restoring hypoxia induced glutathione depletion in hippocampus. Further, Withanolide A increases glutathione biosynthesis in neuronal cells by upregulating GCLC level through Nrf2 pathway in a corticosterone dependenet manner.

No abstract

No abstract

A rapid and high yield microwave assisted synthesis of a series of novel 7,9-bis-(arylidene)-4-methyl-2,6,10-triphenyl-2,3-diazaspiro[4,5]dec-3-ene-1,8-dione has been explored. The spiro diarylidene derivatives having nitrogen atom and ?, ?-unsaturated ketone moiety were synthesized through aldol condensation between 4-methyl-2,6,10-triphenyl-2,3-diazaspiro[4,5]dec-3-ene-1,8-dione and corresponding aryl aldehydes followed by dehydration. The synthesized series of novel spirodiarylidene derivatives were characterized using IR, 1H NMR, 13C NMR and mass spectra. Density Functional Theory (DFT) study was performed by Gaussian 09 software. The antimicrobial activities of the synthesized derivatives were evaluated against two pathogenic Gram positive and Gram negative bacterial strain and three pathogenic fungal species by disk diffusion method. The minimum inhibitory concentration was determined by the microbroth dilution technique. The results of the present study demonstrated that compounds 5a and 5c possessing 4-NO2 and 5-Br-2-OH substituents are found to be more active against Gram positive bacterium Staphylococcus aureus 8 ?g mL-1 and 16 ?g mL-1 respectively and moderately active against Gram negative bacteria Pseudomonas aeruginosa and Escherichia coli compared to other synthetic derivatives. However, none of the synthesized derivatives showed activity against Streptococcus pyrogenes. Compound 5e possessing 2,4,6-(OCH3)3C6H3 moiety exhibited broad spectrum activity against all fungal strains under study but showed no antibacterial activity.

No abstract

No abstract

No abstract

No abstract